Each stage pays for the evidence the next one needs. Shipping a wellness product now funds the validation work that a clinical indication will eventually require — in that order, deliberately.
The ring plus the shift-planning app. Sold direct, no prescription, general wellness positioning. Preorders open now; pilot cohorts get units first and pay nothing.
An adhesive form factor for environments where rings are not permitted — sterile fields, food handling, heavy machinery. Same sensing, seven-day disposable, no charging at all.
Fatigue-risk modelling for a whole unit rather than one person, with roster suggestions that reduce aggregate impairment. Individual data stays private; the employer sees unit-level risk only.
A clinical indication for shift work sleep disorder, pursued only once the pilot base supports it. Not available for sale, not being marketed, and gated behind a pre-submission meeting.
V3LA One is a general wellness product. It is not intended to diagnose, treat, cure or prevent any disease. Programs marked pre-submission are not cleared, not available for sale, and nothing on this page should be read as a claim of clinical benefit. See Regulatory status.
Close the DLMO agreement study, finish design validation on the ring, keep pilots running in two health systems.
General availability, patch prototype in the field, and the first honest look at ninety-day adherence outside a pilot.
Roster Engine as a paid enterprise product where fatigue-related error already carries a cost line.
Only if the data supports it. We would rather be a durable wellness company than a premature medical one.
Pilot cohorts open monthly and get hardware before general availability.